Anesthesia For Cataract Surgery
Published 2025 - 43rd Congress of the ESCRS
Reference: PO446 | Type: Free paper | DOI: 10.82333/xjc3-6v35
Authors: Mateja Jagić* 1 , Maja Bohač 1 , Lucija Žerjav 1 , Ivan Gabrić 1
1Refractive surgery department,University Eye Hospital Svjetlost,Zagreb,Croatia
Purpose
To compare anesthesia techniques in cataract surgery, evaluating their efficacy, risks, and patient outcomes.
Cataracts, the leading cause of blindness, affect ~94 million people, projected to reach 120 million by 2030. Dexmedetomidine, an alpha-2 agonist, is gaining interest for sedation due to its analgesic properties, though its side effects necessitate caution, particularly in hypertensive patients.
Setting
University of Antwerpen
Methods
A literature review (1968–2025) using PubMed, Limo, and Cochrane databases included controlled trials and case series (>100 cases) on cataract surgery anesthesia. A case report on perioperative hypnosis in a high-risk patient was also examined.
Results
Conclusions
All anesthesia techniques are safe and effective, with distinct benefits and risks. Topical anesthesia is favored for uncomplicated cases, but its lack of akinesia may pose challenges. Regional blocks provide superior pain control and akinesia but increase the risk of complications. Among them, Sub-Tenon’s anesthesia offers a favorable balance between efficacy and safety. General anesthesia remains necessary for select cases. The choice should be tailored to patient needs, surgical complexity, and surgeon expertise. Further research is needed to refine recommendations, assess patient preferences, and evaluate cost-effectiveness.